MDMA Praises Reintroduction Of STRONGER Patents Act In Senate
Executive Summary
The Medical Device Manufacturers Association (MDMA) on 10 July praised US Senate reintroduction of the STRONGER Patents Act, designed to strengthen the US patents systems by making it easier and less costly for patent-holders to enforce their patents, including those which are the intellectual property of device-makers. Mirror legislation was simultaneously proposed in the US House.